The Cigna Group
As of Fiscal Year 2025 (ended December 31, 2025)
Key KPIs at a Glance
| Metric | Value |
|---|---|
| Shareholders' net income, GAAP (FY2025) | $5.96 billion, up from $3.43 billion in FY2024 |
| Adjusted income from operations (FY2025) | ~$8.0 billion ($29.84 per share, non-GAAP) |
| GAAP EPS (FY2025) | $22.18 |
| Total customer relationships (year-end 2025) | 188.4 million, up 3% year-over-year |
| Total pharmacy customers | 123.6 million, up 4% year-over-year |
| Total medical customers | 18.12 million, down 5% year-over-year, reflecting the March 2025 divestiture of Medicare-related businesses to HCSC |
| Evernorth (Express Scripts) pharmacy-benefit-manager ranking (FY2025) | #1 among PBMs by prescription-claims volume for the second consecutive year, 2.22 billion adjusted prescription claims (third-party, Drug Channels Institute) |
Sources: Figures are from The Cigna Group's Q4/Full-Year 2025 earnings release. Cigna's segment 'Adjusted Revenues' (Evernorth Health Services and Cigna Healthcare) include intersegment revenues that are eliminated in consolidation, so they do not sum cleanly to the $274.9 billion GAAP consolidated total; a true post-elimination segment revenue split was not found, so no revenue-by-segment pie is included. The market-share pie below is a third-party estimate (American Medical Association 'Competition in Health Insurance' report, 2023 data, as reported by Quartz), the most recent published ranking found.